Haleos Labs Annual General Meeting
Haleos Labs Limited conducted its 20th Annual General Meeting on September 30, 2026. The meeting discussed financial statements, dividend declaration, and various director reappointments.
ALFA Filings
Every announcement, straight from the exchange
Every Haleos Labs annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements with these filters
Haleos Labs Limited conducted its 20th Annual General Meeting on September 30, 2026. The meeting discussed financial statements, dividend declaration, and various director reappointments.
Haleos Labs Limited announced postal ballot results where shareholders approved director reappointment and related party transactions. However, a resolution for managerial remuneration was rejected by shareholders.
Haleos Labs Limited issued a postal ballot notice seeking shareholder approval for director reappointment, managerial remuneration limits, and material related party transactions.
Haleos Labs Limited issued a postal ballot notice for shareholder approval regarding director reappointment, managerial remuneration, and various material related party transactions.
Haleos Labs has announced a postal ballot process to seek shareholder approval for various resolutions, including director reappointment, managerial remuneration, and related party transactions.
Haleos Labs Limited shareholders approved a material related party transaction involving a corporate guarantee for RBL Bank. The guarantee secures an External Commercial Borrowing facility for its subsidiary, Mahi Drugs Private Limited. The resolution was passed with a 99.99% majority via postal ballot.